Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes.
The profiles of 4 acute-phase reactant proteins (APRPs) (haptoglobin (HPT), alpha1 antitrypsin (AAT), alpha1 acid glycoprotein (AGP) and prealbumin (PALB)) have been studied during the evolution of bowel cancer. Serial measurements of these APRPs can add to the information obtained from measurements of the level of CEA and hepatic enzymes during the monitoring of postoperative patients. There is considerable stability in the profile in a given individual in health, Rises of AAT and AGP are associated with metastases. High levels of HPT may suggest involvement of the bowel wall by recurrent cancer. PALB levels tend to reflect the nutritional status. A discriminant function based on the log CEA, AAT and AGP preoperative blood levels can considerably improve on the predictive value attained using CEA levels alone.
D000368:Aged; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D003110:Colonic Neoplasms / Q000097:blood* / Q000276:immunology / Q000601:surgery; D005260:Female; D006242:Haptoglobins / Q000032:analysis*; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009961:Orosomucoid / Q000032:analysis*; D011228:Prealbumin / Q000032:analysis*; D012709:Serum Albumin / Q000032:analysis*; D000515:alpha 1-Antitrypsin / Q000032:analysis*; D005723:gamma-Glutamyltransferase / Q000097:blood
D002272:Carcinoembryonic Antigen; D006242:Haptoglobins; D009961:Orosomucoid; D011228:Prealbumin; D012709:Serum Albumin; D000515:alpha 1-Antitrypsin; D005723:gamma-Glutamyltransferase